Brazil Cardiac Resynchronization Therapy Market Report 2022 to 2030

Brazil Cardiac Resynchronization Therapy Market

$ 3999

Brazil Cardiac Resynchronization Therapy Market valued at $120 Mn in 2022, projected to reach $191 Mn by 2030 with a 6% CAGR. The global rise in heart failure cases, driven by aging populations and lifestyle-related cardiovascular diseases, is a key factor contributing to the expansion of the Cardiac Resynchronization Therapy (CRT) market. Currently, leading participants in this market include Abbott, Boston Scientific, Medtronic, Siemens Healthineers, Johnson & Johnson, Biotronik, LivaNova, MicroPort, Sorin Group, and St. Jude Medical.

ID: IN10BRPH443 CATEGORY: Pharmaceuticals GEOGRAPHY: Brazil AUTHOR: Dr. Medha Sansanwal

Buy Now

Brazil Cardiac Resynchronization Therapy Market Executive Summary

Brazil Cardiac Resynchronization Therapy Market valued at $120 Mn in 2022, projected to reach $191 Mn by 2030 with a 6% CAGR.

Cardiac resynchronization therapy (CRT) involves the use of a pacemaker to correct the heart's rhythm through a minor surgical procedure. Implanted beneath the skin, the CRT pacemaker is responsible for coordinating the timing between the upper (atria) and lower (ventricles) heart chambers, as well as synchronizing the left and right sides of the heart. This intervention is particularly crucial in cases of heart failure, where inadequate pumping results in fluid accumulation in the lungs and legs due to the asynchronous beating of the two lower chambers (ventricles). Additionally, in the presence of severe heart rhythm issues, a physician might suggest an implantable cardioverter-defibrillator (ICD), which can be combined with CRT therapy. The CRT device connects wires from the pacemaker to both sides of the heart, employing biventricular pacing to transmit electrical signals to the ventricles, ensuring coordinated contractions and optimizing overall heart function.

Between 2008 and 2022, Brazil experienced a significant increase in hospitalizations for heart attacks, with monthly averages soaring from 5,282 to 13,645 cases among men (a 158% rise) and from 1,930 to 4,973 cases among women (a 157% increase). Heart attacks now constitute approximately 70 to 75% of all nationwide hospitalizations, with older populations being more susceptible, alongside an escalating prevalence of obesity. Cold weather has emerged as a notable contributing factor, as cases spike during the winter season, witnessing a 27.8% increase in heart attacks for women and a 27.4% increase for men compared to the summer season. The cold induces blood vessel constriction, posing a heightened risk for individuals with pre-existing arterial plaque. Cardiovascular diseases, despite healthcare advances, continue to be the leading cause of death in Brazil, claiming 7,368,654 lives between 2017 and 2021, emphasizing the pressing need for targeted interventions and public health initiatives to address the escalating incidence of heart attacks and associated risk factors.

When the Ministry of Health in Brazil approved the first leadless pacemaker to be used commercially in September 2023, the country marked a major milestone in the development of cardiac care. This less-invasive option has the potential to improve patient outcomes and comfort levels. Notably, advances have also been made in the area of remote monitoring, where experts from the area are actively working on creating and evaluating novel platforms that are tailored for pacemakers. These advancements aim to facilitate improved patient follow-up and ensure timely intervention in the event of any issues. Concurrently, Brazil is contributing to the evolution of pacemaker technology through ongoing clinical trials. These trials, which assess pacemakers of the future with capabilities like AI-powered arrhythmia detection and customized therapy modifications, demonstrate the country's dedication to improving cardiac healthcare through innovative research and development.

Market Dynamics

Market Growth Drivers

Surge in Cardiovascular Disease Cases: Heart attacks constitute approximately 70 to 75% of all nationwide hospitalizations in Brazil, with older populations being more susceptible, alongside an escalating prevalence of obesity. The growing occurrence of cardiovascular diseases in Brazil serves as a prominent factor propelling the expansion of the CRT market.

Growth in Surgical Interventions: There is a 31% increase in Coronary artery bypass graft surgery (CABG) surgeries in Brazil. The escalating frequency of surgical procedures, particularly those associated with cardiovascular ailments, plays a role in fostering the development of the CRT market in Brazil.

Increase in Critical and Intensive Care Facilities: The ongoing expansion of critical care and intensive care units across Brazil emerges as a pivotal factor contributing to the upward trajectory of the CRT market.

Market Restraints

Regulatory Obstacles: The regulatory landscape in Brazil poses challenges for the CRT market, potentially impacting the timely approval and introduction of innovative devices and technologies. Navigating regulatory hurdles may require strategic considerations for market players seeking to establish a presence in the Brazilian healthcare sector.

Restricted Insurance Benefits: Limited insurance coverage in certain areas poses a challenge for medical procedures like CRT, potentially hindering the broad adoption of these therapeutic interventions. This constraint could result in restricted accessibility and affordability for patients seeking cardiac resynchronization therapy in those regions.

Insufficient Knowledge: Many parts of Latin America, including Brazil, grapple with a lack of awareness concerning cardiac diseases, posing a constraint for the CRT market due to limited understanding among the populace.

Healthcare Policies and Regulatory Landscape

In Brazil, the oversight of healthcare policies and regulatory authority about treatment drugs is conducted by key entities, with the National Health Surveillance Agency (ANVISA) serving as a primary authority responsible for ensuring the quality, safety, and efficacy of pharmaceuticals. In conjunction with ANVISA, the Chamber of Medicines assesses the integration of new drugs into the public health system, while both the Brazilian Health Regulatory Chamber (CMED) and the Brazilian Pharmaceutical Market Regulation Chamber contribute to the regulation of drug pricing. Collaboratively, the Ministry of Health works with ANVISA to formulate healthcare strategies and policies, and the National Cancer Institute (INCA) plays a role in shaping policies and guidelines related to cancer. The National Health Council (CNS) ensures community involvement in health decisions, and the National Commission for Ethics in Research (CONEP) oversees the ethical dimensions of clinical trials.

Competitive Landscape

Key Players

Abbott
Boston Scientific
Medtronic
Siemens Healthineers
Johnson & Johnson
Biotronik
LivaNova
MicroPort
Sorin Group
St. Jude Medical

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Brazil Cardiac Resynchronization Therapy Market Segmentation

By Product

CRT-Defibrillator
CRT-Pacemaker

By Age

Below 44 years
45-64 years
65-84 years
Above 85 years

By End-Users

Hospitals
Cardiac Care Centres
Ambulatory Surgical Centres

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.